Malik Rajesh

CIK 00017068532 companiesRESEARCH TRIANGLE PARK, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001706853

Recent Transactions

50 trades

Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−35,700→ 0 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-09-18+17,900→ 177,212 total
Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−89,762→ 87,450 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−36,924→ 0 total
Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−87,450→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−74,500→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−57,333→ 0 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-07-05$2.51/sh−2,475→ 159,312 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-05-13$4.79/sh−8,151→ 161,787 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-12−28,600→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2024-02-12$0.30/sh+28,600→ 198,538 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-02-12$4.62/sh−28,600→ 169,938 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-04$2.94/sh−721→ 169,938 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−2,261→ 170,659 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−758→ 172,920 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-01-03+74,500→ 74,500 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-01-03+37,300→ 173,678 total
Disposition to Issuer
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2023-12-27−25,000→ 0 total
Disposition to Issuer
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2023-12-27−25,614→ 0 total
Disposition to Issuer
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2023-12-27−44,749→ 0 total
Disposition from Tender
POINT Biopharma Global Inc.
Common Stock
2023-12-26−3,700→ 0 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-12-11$4.02/sh−12,400→ 136,378 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2023-12-11$0.39/sh+21,439→ 157,817 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2023-12-11−21,439→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2023-12-11−12,400→ 28,600 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2023-12-11$0.30/sh+12,400→ 148,778 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-12-11$3.06/sh−21,439→ 136,378 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-07-05$2.45/sh−1,361→ 136,378 total
Award
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2023-06-01+44,749→ 44,749 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-05-10+35,000→ 137,739 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-05$5.41/sh−729→ 102,739 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-04$5.58/sh−1,639→ 103,468 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2023-01-03+35,700→ 35,700 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-01-03+17,900→ 105,107 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2022-12-15−14,000→ 41,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-12-15$0.30/sh+14,000→ 87,207 total
Purchase
POINT Biopharma Global Inc.
Common Stock
2022-11-28$6.66/sh+3,700→ 3,700 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-09-13$15.71/sh−18,000→ 73,207 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2022-09-13−18,000→ 21,439 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-09-13$0.39/sh+18,000→ 91,207 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-07-05$5.17/sh−648→ 73,207 total
Award
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2022-06-02+25,614→ 25,614 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-01−10,000→ 55,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-02-01$0.30/sh+10,000→ 73,855 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-01-05$10.61/sh−1,445→ 63,855 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2022-01-03+53,000→ 53,000 total
Award
G1 Therapeutics, Inc.
Common Stock
2022-01-03+12,000→ 65,300 total
Award
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2021-07-06+25,000→ 25,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-05-10$0.30/sh+10,000→ 53,300 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-10−10,000→ 65,000 total

Companies

Recent Filings

Address

C/O G1 THERAPEUTICS, INC. 79 T.W. ALEXANDER DRIVE

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov